|
1
|
Subramaniam S, Thakur RK, Yadav VK, Nanda
R, Chowdhury S and Agrawal A: Lung cancer biomarkers: State of the
art. J Carcinog. 12:32013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Verdecchia A, Francisci S, Brenner H,
Gatta G, Micheli A, Mangone L and Kunkler I; EUROCARE-4 Working
Group. Recent cancer survival in Europe: A 2000–02 period analysis
of EUROCARE-4 data. Lancet Oncol. 8:784–796. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de Boer A, Vos E and Bast A:
Implementation of the nutrition and health claim regulation - the
case of antioxidants. Regul Toxicol Pharmacol. 68:475–487. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zicker SC, Wedekind KJ and Jewell DE:
Antioxidants in veterinary nutrition. Vet Clin North Am Small Anim
Pract. 36:1183–1198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mandel S, Amit T, Reznichenko L, Weinreb O
and Youdim MB: Green tea catechins as brain-permeable, natural iron
chelators-antioxidants for the treatment of neurodegenerative
disorders. Mol Nutr Food Res. 50:229–234. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang DS, Li ZL, Peng WB, Yang YP, Wang X,
Liu KC, Li XL and Xiao WL: Three new prenylated flavonoids from
Macaranga denticulata and their anticancer effects. Fitoterapia.
103:165–170. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rezk BM, Haenen GR, van der Vijgh WJ and
Bast A: The anti-oxidant activity of phloretin: The disclosure of a
new antioxidant pharmacophore in flavonoids. Biochem Biophys Res
Commun. 295:9–13. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang S and Morris ME: Effects of the
flavonoids biochanin A, morin, phloretin, and silymarin on
P-glycoprotein-mediated transport. J Pharmacol Exp Ther.
304:1258–1267. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pohl C, Will F, Dietrich H and Schrenk D:
Cytochrome P450 1A1 expression and activity in Caco-2 cells:
Modulation by apple juice extract and certain apple polyphenols. J
Agric Food Chem. 54:10262–10268. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nguyen H, Zhang S and Morris ME: Effect of
flavonoids on MRP1-mediated transport in Panc-1 cells. J Pharm Sci.
92:250–257. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Boyer J and Liu RH: Apple phytochemicals
and their health benefits. Nutr J. 3:52004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kelly PN and Strasser A: The role of Bcl-2
and its pro-survival relatives in tumourigenesis and cancer
therapy. Cell Death Differ. 18:1414–1424. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xin M and Deng X: Nicotine inactivation of
the proapoptotic function of Bax through phosphorylation. J Biol
Chem. 280:10781–10789. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bayramoglu A, Gunes HV, Metintas M,
Değirmenci I, Mutlu F and Alataş F: The association of MMP-9 enzyme
activity, MMP-9 C1562T polymorphism, and MMP-2 and -9 and TIMP-1,
-2, -3, and -4 gene expression in lung cancer. Genet Test Mol
Biomarkers. 13:671–678. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang KC, Tsai CY, Wang YJ, Wei PL, Lee CH,
Chen JH, Wu CH and Ho YS: Apple polyphenol phloretin potentiates
the anticancer actions of paclitaxel through induction of apoptosis
in human hep G2 cells. Mol Carcinog. 48:420–431. 2009. View Article : Google Scholar
|
|
16
|
Nelson JA and Falk RE: Phloridzin and
phloretin inhibition of 2-deoxy-D-glucose uptake by tumor cells in
vitro and in vivo. Anticancer Res. 13A:2293–2299. 1993.
|
|
17
|
Nelson JA and Falk RE: The efficacy of
phloridzin and phloretin on tumor cell growth. Anticancer Res.
13A:2287–2292. 1993.
|
|
18
|
Zhu SP, Liu G, Wu XT, Chen FX, Liu JQ,
Zhou ZH, Zhang JF and Fei SJ: The effect of phloretin on human γδ T
cells killing colon cancer SW-1116 cells. Int Immunopharmacol.
15:6–14. 2013. View Article : Google Scholar
|
|
19
|
Karunagaran D, Joseph J and Kumar TR: Cell
growth regulation. Adv Exp Med Biol. 595:245–268. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rong Y and Distelhorst CW: Bcl-2 protein
family members: Versatile regulators of calcium signaling in cell
survival and apoptosis. Annu Rev Physiol. 70:73–91. 2008.
View Article : Google Scholar
|
|
21
|
Park HJ, Jeon YK, You DH and Nam MJ:
Daidzein causes cytochrome c-mediated apoptosis via the Bcl-2
family in human hepatic cancer cells. Food Chem Toxicol.
60:542–549. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fennell DA: Caspase regulation in
non-small cell lung cancer and its potential for therapeutic
exploitation. Clin Cancer Res. 11:2097–2105. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Balzer EM and Konstantopoulos K:
Intercellular adhesion: Mechanisms for growth and metastasis of
epithelial cancers. Wiley Interdiscip Rev Syst Biol Med. 4:171–181.
2012. View
Article : Google Scholar
|
|
24
|
Guruvayoorappan C and Kuttan G:
Amentoflavone inhibits experimental tumor metastasis through a
regulatory mechanism involving MMP-2, MMP-9, prolyl hydroxylase,
lysyl oxidase, VEGF, ERK-1, ERK-2, STAT-1, NM23 and cytokines in
lung tissues of C57BL/6 mice. Immunopharmacol Immunotoxicol.
30:711–727. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen RX, Xia YH, Xue TC, Zhang H and Ye
SL: Down-regulation of osteopontin inhibits metastasis of
hepatocellular carcinoma cells via a mechanism involving MMP-2 and
uPA. Oncol Rep. 25:803–808. 2011.
|
|
26
|
Borkham-Kamphorst E, Alexi P, Tihaa L,
Haas U and Weiskirchen R: Platelet-derived growth factor-D
modulates extracellular matrix homeostasis and remodeling through
TIMP-1 induction and attenuation of MMP-2 and MMP-9 gelatinase
activities. Biochem Biophys Res Commun. 457:307–313. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Davis ME, Gumucio JP, Sugg KB, Bedi A and
Mendias CL: MMP inhibition as a potential method to augment the
healing of skeletal muscle and tendon extracellular matrix. J Appl
Physiol. 115:884–891. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang R, Ke ZF, Wang F, Zhang WH, Wang YF,
Li SH and Wang LT: GOLPH3 overexpression is closely correlated with
poor prognosis in human non-small cell lung cancer and mediates its
metastasis through upregulating MMP-2 and MMP-9. Cell Physiol
Biochem. 35:969–982. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu X, Chen L, Xu B, Xie Q, Sun M, Deng X,
Wu C and Jiang J: Increased MT2-MMP expression in gastric cancer
patients is associated with poor prognosis. Int J Clin Exp Pathol.
8:1985–1990. 2015.PubMed/NCBI
|
|
30
|
El-Badrawy MK, Yousef AM, Shaalan D and
Elsamanoudy AZ: Matrix metalloproteinase-9 expression in lung
cancer patients and its relation to serum MMP-9 activity,
pathologic type, and prognosis. J Bronchol Interv Pulmonol.
21:327–334. 2014. View Article : Google Scholar
|
